Blood biomarkers of inflammation and brain-derived neurotrophic factor can not be used to assess the effectiveness of collagen mesotherapy in chronic cervical myofascial pain syndrome. A pilot single-blind randomized study

Rheumatology International 2026

View at publisher
Authors: Kamil Koszela, Agnieszka Paradowska‐Gorycka, Brygida Kwiatkowska, Marta Woldańska-Okońska, Barbara Stypińska, Adam Ejma-Multański, Robert Gasik
DOI: 10.1007/s00296-026-06094-4
Cited by: 1
References: 33

Fields of Study & Subjects

Myofascial pain diagnosis and treatment Musculoskeletal pain and rehabilitation Spine and Intervertebral Disc Pathology

Publication details

Journal / source
Rheumatology International
Publisher
Springer Science and Business Media LLC
Volume
46
Issue
3
Publication date
2 March 2026
Language
EN